|
|
|
Insider
Information: |
Afeyan Noubar |
Relationship: |
Director, 10% Owner |
City: |
Lexington |
State: |
MA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
20 |
|
Direct
Shares |
7,980,025 |
|
Indirect Shares
|
111,880,829 |
|
|
Direct
Value |
$14,010,630 |
|
|
Indirect Value
|
$98,146,267 |
|
|
Total
Shares |
119,860,854 |
|
|
Total
Value |
$112,156,897 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
3
|
0
|
Stock
price went up :
|
1
|
0
|
Stock
price went down : |
2
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
-42.1%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Color Kinetics Inc |
CLRK |
Director |
2005-10-03 |
83,062 |
2005-10-03 |
12,000 |
Premium* |
|
Agenus Inc |
AGEN |
Director |
2006-12-14 |
0 |
2006-12-14 |
0 |
Premium* |
|
Helicos Biosciences Corp |
HLCSQ |
Director, 10% Owner |
2009-09-18 |
0 |
2009-09-18 |
12,192,640 |
Premium* |
|
Receptos, Inc. |
RCPT |
10% Owner |
2013-11-18 |
1,693,551 |
|
0 |
Premium* |
|
DNIB Upwind Inc |
BIND |
Director, 10% Owner |
2013-09-25 |
0 |
2013-09-25 |
1,562,616 |
Premium* |
|
Bg Medicine, Inc. |
BGMD |
Director, 10% Owner |
2015-12-09 |
0 |
2015-12-09 |
1,286,274 |
Premium* |
|
Editas Medicine, Inc. |
EDIT |
10% Owner |
2016-02-08 |
3,964,256 |
2016-02-08 |
991,060 |
Premium* |
|
Cartesian Therapeutics, Inc |
RNAC |
10% Owner |
2016-06-27 |
0 |
2016-06-27 |
1,651,862 |
Premium* |
|
Kaleido Biosciences, Inc. |
KLDO |
10% Owner |
|
0 |
2021-02-08 |
14,907,627 |
Premium* |
|
Transmedics Group, Inc. |
TMDX |
10% Owner |
|
0 |
2019-10-29 |
120,595 |
Premium* |
|
Seres Therapeutics, Inc. |
MCRB |
10% Owner |
2019-06-18 |
15,141 |
2022-07-05 |
17,617,352 |
Premium* |
|
Moderna, Inc. |
MRNA |
|
2024-07-31 |
2,224,015 |
2024-07-31 |
4,632,149 |
Premium* |
|
Axcella Health Inc. |
AXLA |
10% Owner |
2020-05-18 |
0 |
2022-10-13 |
8,850,296 |
Premium* |
|
Evelo Biosciences Inc |
EVLO |
|
2020-06-29 |
0 |
2023-07-11 |
4,977,588 |
Premium* |
|
Codiak Biosciences, Inc. |
CDAK |
10% Owner |
|
0 |
2022-09-15 |
1,674,869 |
Premium* |
|
Foghorn Therapeutics Inc. |
FHTX |
10% Owner |
2020-10-27 |
0 |
2020-10-27 |
1,851,801 |
Premium* |
|
Sigilon Therapeutics, Inc. |
SGTX |
10% Owner |
2020-12-08 |
0 |
2023-08-11 |
0 |
Premium* |
|
Sana Biotechnology, Inc. |
SANA |
10% Owner |
2021-02-08 |
0 |
2023-09-13 |
581,695 |
Premium* |
|
Rubius Therapeutics, Inc. |
RUBY |
Director, 10% Owner |
2021-03-19 |
0 |
2021-03-19 |
17,253,519 |
Premium* |
|
Omega Therapeutics, Inc. |
OMGA |
Director, 10% Owner |
2021-08-03 |
0 |
2023-02-27 |
21,716,886 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
155 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 6 of 7
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
MRNA |
Moderna, Inc. |
Director |
|
2022-06-29 |
4 |
AS |
$140.47 |
$1,404,700 |
D/D |
(10,000) |
2,517,209 |
0 |
- |
|
MRNA |
Moderna, Inc. |
|
|
2024-05-29 |
4 |
AS |
$141.01 |
$2,901,585 |
D/D |
(20,000) |
1,961,931 |
0 |
- |
|
MRNA |
Moderna, Inc. |
|
|
2024-05-22 |
4 |
AS |
$142.95 |
$2,363,556 |
D/D |
(15,000) |
1,981,931 |
0 |
- |
|
MRNA |
Moderna, Inc. |
|
|
2024-06-12 |
4 |
AS |
$142.97 |
$2,208,071 |
D/D |
(15,000) |
2,314,015 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Director |
|
2021-02-24 |
4 |
AS |
$144.17 |
$256,378,924 |
I/I |
(1,753,697) |
12,869,462 |
0 |
- |
|
MRNA |
Moderna, Inc. |
|
|
2024-06-05 |
4 |
AS |
$145.91 |
$2,268,804 |
D/D |
(15,000) |
1,946,931 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Director |
|
2022-06-01 |
4 |
AS |
$146.31 |
$1,463,100 |
D/D |
(10,000) |
2,547,209 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Director |
|
2022-06-08 |
4 |
AS |
$147.47 |
$1,474,700 |
D/D |
(10,000) |
2,537,209 |
0 |
- |
|
MRNA |
Moderna, Inc. |
|
|
2024-06-11 |
4 |
S |
$148.29 |
$30,087,339 |
I/I |
(202,832) |
1,528,557 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Director |
|
2022-11-02 |
4 |
AS |
$154.20 |
$1,542,000 |
D/D |
(10,000) |
2,347,209 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Director |
|
2022-07-06 |
4 |
AS |
$154.85 |
$1,548,500 |
D/D |
(10,000) |
2,507,209 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Director |
|
2021-02-22 |
4 |
AS |
$159.18 |
$301,636,406 |
I/I |
(1,836,766) |
17,570,797 |
0 |
- |
|
MRNA |
Moderna, Inc. |
|
|
2023-02-22 |
4 |
AS |
$160.35 |
$1,603,500 |
D/D |
(10,000) |
2,197,209 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Director |
|
2022-07-27 |
4 |
AS |
$161.00 |
$1,610,000 |
D/D |
(10,000) |
2,477,209 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Director |
|
2022-11-09 |
4 |
AS |
$162.50 |
$1,625,000 |
D/D |
(10,000) |
2,337,209 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Director |
|
2023-02-08 |
4 |
AS |
$164.60 |
$3,356,761 |
D/D |
(20,000) |
2,217,209 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Director |
|
2022-08-17 |
4 |
AS |
$165.24 |
$1,652,400 |
D/D |
(10,000) |
2,447,209 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Director |
|
2022-07-20 |
4 |
AS |
$167.00 |
$1,670,000 |
D/D |
(10,000) |
2,487,209 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Director |
|
2022-08-03 |
4 |
AS |
$167.99 |
$1,679,900 |
D/D |
(10,000) |
2,467,209 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Director |
|
2022-07-13 |
4 |
AS |
$168.88 |
$1,688,800 |
D/D |
(10,000) |
2,497,209 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Director |
|
2022-12-07 |
4 |
AS |
$172.16 |
$1,721,600 |
D/D |
(10,000) |
2,297,209 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Director |
|
2023-02-15 |
4 |
AS |
$173.17 |
$1,731,700 |
D/D |
(10,000) |
2,207,209 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Director |
|
2022-11-30 |
4 |
AS |
$173.52 |
$1,735,200 |
D/D |
(10,000) |
2,307,209 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Director |
|
2022-08-10 |
4 |
AS |
$174.09 |
$1,740,900 |
D/D |
(10,000) |
2,457,209 |
0 |
- |
|
MRNA |
Moderna, Inc. |
Director |
|
2022-11-16 |
4 |
AS |
$184.25 |
$1,842,500 |
D/D |
(10,000) |
2,327,209 |
0 |
- |
|
155 Records found
|
|
Page 6 of 7 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|